Challenges Associated With Comparability For Cell-Based Products

During this Cell & Gene Live, "Scaling Cell Therapies Part 2: Establishing Comparability in Manufacturing," Cell & Gene's Chief Editor, Erin Harris, Michael Blackton, former SVP Cell Therapy Manufacturing at Nurix Therapeutics, and John Lee, SVP, Head of Cell Therapy at Center for Breakthrough Medicines, talk through the CGT sector's greatest struggles with comparability. Indeed in this segment, Blackton and Lee cover the sector's biggest challenges to date from the need to truly understand the product to precise analytics and eliminating silos, and more.

View the full presentation on-demand here.